← Leaderboards
Ying Yan
University Of Nebraska Medical Center
$1,295,701
Attributed
$1,295,701
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $341.5K · FY2021–24$500K$375K$250K$125K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$1,295,701 · 1
By mechanism
R01$1,295,701 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- Moorthy P. Ponnusamy$2,721,536
- Maneesh Jain$6,905,007
- Amarnath Natarajan$8,497,174
- J. Alan Diehl$22,210,909
- Ravi Salgia$9,622,551
Others in their field
Other Emerging Leaders on “Mouse Model”
- James Dale Berry · Brigham And Women'S Hospital$25,017,559
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$13,186,126
- Nuno Macarico Da Costa · Allen Institute$11,726,937
- Forrest Christie Collman · Allen Institute$11,726,937
- Jacqueline K White · Jackson Laboratory$11,670,339
- Thomas Dick · Rbhs-New Jersey Medical School$11,611,284
Research focus
Mouse ModelPhosphoric Monoester HydrolasesMalignant - DescriptorMalignant NeoplasmsOncogenicPathway InteractionsCancer InitiationKnock-DownInnovationMalignant Neoplasm Of PancreasNeoplasm MetastasisNew Therapeutic TargetComplexPancreatic Cancer CellsCritical PathwaysCul1 GeneCatalytic DomainAnchorage-Independent GrowthCellsFamilyGenesF-Box ProteinsAutomobile DrivingPhosphorylation
Grant awards (6)
PR55-alpha controlled PP2A in the regulation of the Hippo/YAP pathway$307,000
R01 · FY2024 · GM · contact PI
CFX Opus 96 Real-Time PCR System for precision genotyping and phenotyping$34,465
R01 · FY2024 · GM · contact PI
PR55-alpha controlled PP2A in the regulation of the Hippo/YAP pathway$307,000
R01 · FY2023 · GM · contact PI
Maxwell RSC rapid DNA/RNA purification instrument for high-quality genotyping and phenotyping research$34,069
R01 · FY2023 · GM · contact PI
PR55-alpha controlled PP2A in the regulation of the Hippo/YAP pathway$307,000
R01 · FY2022 · GM · contact PI
PR55-alpha controlled PP2A in the regulation of the Hippo/YAP pathway$306,167
R01 · FY2021 · GM · contact PI